Compare $DCOY vs $VCNX | Chartloom

Compare

$DCOY vs $VCNX

Decoy Therapeutics Inc · Vaccinex Inc

DCOY

Decoy Therapeutics Inc

VCNX

Vaccinex Inc

Compare $DCOY vs $VCNX

Comparing Decoy Therapeutics Inc and Vaccinex Inc

DCOYDecoy Therapeutics Inc

VCNXVaccinex Inc

DCOYDecoy Therapeutics Inc

Market cap

$779K

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-81.2%

52W performance

-97.0%

FCF yield

-1073.9%

VCNXVaccinex Inc

Market cap

$3M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

5.4%

YTD performance

0.9%

52W performance

29.8%

FCF yield

-530.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

DCOY

VCNX

Detailed metrics comparison

DCOY

Decoy Therapeutics Inc

VCNX

Vaccinex Inc

Market Cap

DCOY$779K

VCNX$3M

Enterprise Value

DCOY$-8M

VCNX$2M

Price

DCOY$1.47

VCNX$1.14

P/E Ratio

DCOYN/A

VCNXN/A

P/S Ratio

DCOY3.42x

VCNX5.08x

EV/Sales

DCOY-33.00x

VCNX3.28x

EV/EBITDA

DCOY0.00x

VCNX0.00x

P/B Ratio

DCOY0.75x

VCNX1.15x

P/FCF Ratio

DCOYN/A

VCNXN/A

EV/FCF

DCOY0.90x

VCNX-0.12x

PEG Ratio

DCOYN/A

VCNXN/A

Forward P/E (NTM)

DCOYN/A

VCNXN/A

Forward P/S (NTM)

DCOYN/A

VCNXN/A

Revenue (TTM)

DCOY$228K

VCNX$601K

Revenue Growth (YoY)

DCOYN/A

VCNX5.4%

Forward Rev Growth

DCOY0.0%

VCNX0.0%

Gross Margin (TTM)

DCOY48.6%

VCNX99.7%

Operating Margin (TTM)

DCOY0.0%

VCNX0.0%

EBITDA Margin (TTM)

DCOY-2668.9%

VCNX-3101.7%

Net Margin (TTM)

DCOY-6348.7%

VCNX-3100.5%

FCF Margin (TTM)

DCOY-3676.1%

VCNX-2696.8%

Net Income (TTM)

DCOY$-14M

VCNX$-19M

FCF (TTM)

DCOY$-8M

VCNX$-16M

EPS (TTM)

DCOY-$27.16

VCNX-$5.78

ROE (TTM)

DCOY-31523.0%

VCNX-14678.0%

ROA (TTM)

DCOY-16715.0%

VCNX-43375.0%

ROIC (TTM)

DCOY-31523.0%

VCNX-14238.0%

Cash

DCOY$8M

VCNX$1M

Debt

DCOY$0

VCNX$25K

Net Cash/Debt

DCOY$8M

VCNX$1M

Current Ratio (TTM)

DCOY1.83x

VCNX0.50x

Quick Ratio (TTM)

DCOY1.77x

VCNX0.38x

Debt/Equity (TTM)

DCOY0.00x

VCNX0.03x

Debt/Assets (TTM)

DCOY0.0%

VCNX0.0%

Interest Coverage (TTM)

DCOYN/A

VCNXN/A

Net Debt/EBITDA (TTM)

DCOY0.00x

VCNX0.00x

Beta

DCOY0.68

VCNX0.73

52W Performance

DCOY-97.0%

VCNX29.8%

YTD Performance

DCOY-81.2%

VCNX0.9%

% from 52W High

DCOY-97.4%

VCNX-24.0%

% from 52W Low

DCOY0.7%

VCNX267.7%

Asset Turnover (TTM)

DCOY0.03x

VCNX0.14x

FCF Yield (TTM)

DCOY-1073.9%

VCNX-530.5%

Earnings Yield (TTM)

DCOY-1854.7%

VCNX-609.9%

Dividend Yield (TTM)

DCOYN/A

VCNXN/A

Rule of 40

DCOY-3,676.1

VCNX-2,691.4

EV/GP/RG

DCOYN/A

VCNXN/A

Ticker research

View DCOY research View VCNX research

Metric	DCOY Decoy Therapeutics Inc	VCNX Vaccinex Inc
Market & Valuation
Market Cap	$779K	$3M
Enterprise Value	$-8M	$2M
Price	$1.47	$1.14
P/E Ratio	N/A	N/A
P/S Ratio	3.42x	5.08x
EV/Sales	-33.00x	3.28x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.75x	1.15x
P/FCF Ratio	N/A	N/A
EV/FCF	0.90x	-0.12x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$228K	$601K
Revenue Growth (YoY)	N/A	5.4%
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	48.6%	99.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-2668.9%	-3101.7%
Net Margin (TTM)	-6348.7%	-3100.5%
FCF Margin (TTM)	-3676.1%	-2696.8%
Net Income (TTM)	$-14M	$-19M
FCF (TTM)	$-8M	$-16M
EPS (TTM)	-$27.16	-$5.78
ROE (TTM)	-31523.0%	-14678.0%
ROA (TTM)	-16715.0%	-43375.0%
ROIC (TTM)	-31523.0%	-14238.0%
Financial Health
Cash	$8M	$1M
Debt	$0	$25K
Net Cash/Debt	$8M	$1M
Current Ratio (TTM)	1.83x	0.50x
Quick Ratio (TTM)	1.77x	0.38x
Debt/Equity (TTM)	0.00x	0.03x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.68	0.73
52W Performance	-97.0%	29.8%
YTD Performance	-81.2%	0.9%
% from 52W High	-97.4%	-24.0%
% from 52W Low	0.7%	267.7%
Efficiency & Yields
Asset Turnover (TTM)	0.03x	0.14x
FCF Yield (TTM)	-1073.9%	-530.5%
Earnings Yield (TTM)	-1854.7%	-609.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-3,676.1	-2,691.4
EV/GP/RG	N/A	N/A
Ticker research	View DCOY research	View VCNX research

Valuation

P/S Ratio

DCOY

3.42x

VCNX

5.08x

EV/FCF

VCNX

-0.12x

DCOY

0.90x

Growth & revenue

Revenue Growth TTM

VCNX

5.4%

Forward Revenue Growth

DCOY

0.0%

VCNX

0.0%

Profitability & performance

Gross Margin

VCNX

99.7%

DCOY

48.6%

ROE

VCNX

-14678.0%

DCOY

-31523.0%

FCF Yield %

VCNX

-530.5%

DCOY

-1073.9%

52-Week Performance

VCNX

29.8%

DCOY

-97.0%

Detailed metrics comparison

DCOY

Decoy Therapeutics Inc

VCNX

Vaccinex Inc

Market Cap

DCOY$779K

VCNX$3M

Enterprise Value

DCOY$-8M

VCNX$2M

Price

DCOY$1.47

VCNX$1.14

P/E Ratio

DCOYN/A

VCNXN/A

P/S Ratio

DCOY3.42x

VCNX5.08x

EV/Sales

DCOY-33.00x

VCNX3.28x

EV/EBITDA

DCOY0.00x

VCNX0.00x

P/B Ratio

DCOY0.75x

VCNX1.15x

P/FCF Ratio

DCOYN/A

VCNXN/A

EV/FCF

DCOY0.90x

VCNX-0.12x

PEG Ratio

DCOYN/A

VCNXN/A

Forward P/E (NTM)

DCOYN/A

VCNXN/A

Forward P/S (NTM)

DCOYN/A

VCNXN/A

Revenue (TTM)

DCOY$228K

VCNX$601K

Revenue Growth (YoY)

DCOYN/A

VCNX5.4%

Forward Rev Growth

DCOY0.0%

VCNX0.0%

Gross Margin (TTM)

DCOY48.6%

VCNX99.7%

Operating Margin (TTM)

DCOY0.0%

VCNX0.0%

EBITDA Margin (TTM)

DCOY-2668.9%

VCNX-3101.7%

Net Margin (TTM)

DCOY-6348.7%

VCNX-3100.5%

FCF Margin (TTM)

DCOY-3676.1%

VCNX-2696.8%

Net Income (TTM)

DCOY$-14M

VCNX$-19M

FCF (TTM)

DCOY$-8M

VCNX$-16M

EPS (TTM)

DCOY-$27.16

VCNX-$5.78

ROE (TTM)

DCOY-31523.0%

VCNX-14678.0%

ROA (TTM)

DCOY-16715.0%

VCNX-43375.0%

ROIC (TTM)

DCOY-31523.0%

VCNX-14238.0%

Cash

DCOY$8M

VCNX$1M

Debt

DCOY$0

VCNX$25K

Net Cash/Debt

DCOY$8M

VCNX$1M

Current Ratio (TTM)

DCOY1.83x

VCNX0.50x

Quick Ratio (TTM)

DCOY1.77x

VCNX0.38x

Debt/Equity (TTM)

DCOY0.00x

VCNX0.03x

Debt/Assets (TTM)

DCOY0.0%

VCNX0.0%

Interest Coverage (TTM)

DCOYN/A

VCNXN/A

Net Debt/EBITDA (TTM)

DCOY0.00x

VCNX0.00x

Beta

DCOY0.68

VCNX0.73

52W Performance

DCOY-97.0%

VCNX29.8%

YTD Performance

DCOY-81.2%

VCNX0.9%

% from 52W High

DCOY-97.4%

VCNX-24.0%

% from 52W Low

DCOY0.7%

VCNX267.7%

Asset Turnover (TTM)

DCOY0.03x

VCNX0.14x

FCF Yield (TTM)

DCOY-1073.9%

VCNX-530.5%

Earnings Yield (TTM)

DCOY-1854.7%

VCNX-609.9%

Dividend Yield (TTM)

DCOYN/A

VCNXN/A

Rule of 40

DCOY-3,676.1

VCNX-2,691.4

EV/GP/RG

DCOYN/A

VCNXN/A

Ticker research

View DCOY research View VCNX research

Metric	DCOY Decoy Therapeutics Inc	VCNX Vaccinex Inc
Market & Valuation
Market Cap	$779K	$3M
Enterprise Value	$-8M	$2M
Price	$1.47	$1.14
P/E Ratio	N/A	N/A
P/S Ratio	3.42x	5.08x
EV/Sales	-33.00x	3.28x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.75x	1.15x
P/FCF Ratio	N/A	N/A
EV/FCF	0.90x	-0.12x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$228K	$601K
Revenue Growth (YoY)	N/A	5.4%
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	48.6%	99.7%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-2668.9%	-3101.7%
Net Margin (TTM)	-6348.7%	-3100.5%
FCF Margin (TTM)	-3676.1%	-2696.8%
Net Income (TTM)	$-14M	$-19M
FCF (TTM)	$-8M	$-16M
EPS (TTM)	-$27.16	-$5.78
ROE (TTM)	-31523.0%	-14678.0%
ROA (TTM)	-16715.0%	-43375.0%
ROIC (TTM)	-31523.0%	-14238.0%
Financial Health
Cash	$8M	$1M
Debt	$0	$25K
Net Cash/Debt	$8M	$1M
Current Ratio (TTM)	1.83x	0.50x
Quick Ratio (TTM)	1.77x	0.38x
Debt/Equity (TTM)	0.00x	0.03x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.68	0.73
52W Performance	-97.0%	29.8%
YTD Performance	-81.2%	0.9%
% from 52W High	-97.4%	-24.0%
% from 52W Low	0.7%	267.7%
Efficiency & Yields
Asset Turnover (TTM)	0.03x	0.14x
FCF Yield (TTM)	-1073.9%	-530.5%
Earnings Yield (TTM)	-1854.7%	-609.9%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-3,676.1	-2,691.4
EV/GP/RG	N/A	N/A
Ticker research	View DCOY research	View VCNX research